-
Je něco špatně v tomto záznamu ?
Experimental Design for Determination of Effects of Superdisintegrant Combinations on Liquisolid System Properties
B. Vraníková, S. Pavloková, J. Gajdziok,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
- MeSH
- farmaceutická chemie metody MeSH
- farmaceutické pomocné látky chemická syntéza farmakokinetika MeSH
- lékové formy MeSH
- pomocné látky chemická syntéza farmakokinetika MeSH
- povidon chemická syntéza metabolismus MeSH
- rozpustnost MeSH
- škrob analogy a deriváty chemická syntéza farmakokinetika MeSH
- sodná sůl karboxymethylcelulosy chemická syntéza farmakokinetika MeSH
- uvolňování léčiv MeSH
- výzkumný projekt MeSH
- Publikační typ
- časopisecké články MeSH
The preparation of liquisolid systems presents a promising and innovative possibility for enhancing dissolution profiles and improving the bioavailability of poorly soluble drugs. This study aims to evaluate the differences in the properties of liquisolid systems containing combinations of 3 commercially used superdisintegrants (sodium starch glycolate, crospovidone, and croscarmellose sodium). Multiple regression models and contour plots were used to study how the amount and the type of superdisintegrant used affected the quality parameters of liquisolid tablets. The results revealed that an increased amount of crospovidone in the mixture improves disintegration and wetting time and enhances drug release from the prepared liquisolid tablets. Moreover, it was observed that a binary blend of crospovidone and sodium starch glycolate improved tablet disintegration. Considering the obtained results, it could be stated that crospovidone showed the best properties to be used as superdisintegrant for the preparation of liquisolid systems containing rosuvastatin.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18016879
- 003
- CZ-PrNML
- 005
- 20181011123541.0
- 007
- ta
- 008
- 180515s2017 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.xphs.2016.11.002 $2 doi
- 035 __
- $a (PubMed)27923491
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Vraníková, Barbora, $d 1987- $7 xx0228025 $u Department of Pharmaceutics, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Brno 612 42, Czech Republic; Department of Pharmaceutical Technology, Faculty of Pharmacy in Hradec Králové, Charles University, Hradec Králové 500 05, Czech Republic.
- 245 10
- $a Experimental Design for Determination of Effects of Superdisintegrant Combinations on Liquisolid System Properties / $c B. Vraníková, S. Pavloková, J. Gajdziok,
- 520 9_
- $a The preparation of liquisolid systems presents a promising and innovative possibility for enhancing dissolution profiles and improving the bioavailability of poorly soluble drugs. This study aims to evaluate the differences in the properties of liquisolid systems containing combinations of 3 commercially used superdisintegrants (sodium starch glycolate, crospovidone, and croscarmellose sodium). Multiple regression models and contour plots were used to study how the amount and the type of superdisintegrant used affected the quality parameters of liquisolid tablets. The results revealed that an increased amount of crospovidone in the mixture improves disintegration and wetting time and enhances drug release from the prepared liquisolid tablets. Moreover, it was observed that a binary blend of crospovidone and sodium starch glycolate improved tablet disintegration. Considering the obtained results, it could be stated that crospovidone showed the best properties to be used as superdisintegrant for the preparation of liquisolid systems containing rosuvastatin.
- 650 _2
- $a sodná sůl karboxymethylcelulosy $x chemická syntéza $x farmakokinetika $7 D002266
- 650 _2
- $a farmaceutická chemie $x metody $7 D002626
- 650 _2
- $a lékové formy $7 D004304
- 650 _2
- $a uvolňování léčiv $7 D065546
- 650 _2
- $a pomocné látky $x chemická syntéza $x farmakokinetika $7 D005079
- 650 _2
- $a farmaceutické pomocné látky $x chemická syntéza $x farmakokinetika $7 D010592
- 650 _2
- $a povidon $x chemická syntéza $x metabolismus $7 D011205
- 650 _2
- $a výzkumný projekt $7 D012107
- 650 _2
- $a rozpustnost $7 D012995
- 650 _2
- $a škrob $x analogy a deriváty $x chemická syntéza $x farmakokinetika $7 D013213
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Pavloková, Sylvie $u Department of Pharmaceutics, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Brno 612 42, Czech Republic.
- 700 1_
- $a Gajdziok, Jan $u Department of Pharmaceutics, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Brno 612 42, Czech Republic. Electronic address: gajdziokj@vfu.cz.
- 773 0_
- $w MED00002895 $t Journal of pharmaceutical sciences $x 1520-6017 $g Roč. 106, č. 3 (2017), s. 817-825
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27923491 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180515 $b ABA008
- 991 __
- $a 20181011124032 $b ABA008
- 999 __
- $a ok $b bmc $g 1300503 $s 1013719
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 106 $c 3 $d 817-825 $e 20161205 $i 1520-6017 $m Journal of pharmaceutical sciences $n J Pharm Sci $x MED00002895
- LZP __
- $a Pubmed-20180515
